22 May 2013
Keywords: access, pharma, gains, patents, trade, marks, amlexanox
Article | 29 July 2002
Access Pharmaceutical of the USA has announced that it has acquired fromGlaxoSmithKline the patents and trade marks for amlexanox relating ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 July 2002
© 2013 thepharmaletter.com